product development programs. They focus on early to mid-stage investment opportunities in private companies and undervalued public companies. Through strategic CRO service agreements with Cato Research, They have invested their CRO Service Capitalâ„¢ in innovative therapeutics, medical devices and stem cell technologies that improve Pharma's Research and Development productivity. If strategic outsourcing for development and regulatory support is a core component of a company's business plan, then their investment model can make a positive difference in the company's overall success.